<p>Cysteine protease cathepsin L regulates&nbsp;glucocerebrosidase stability and may be a therapeutic target&nbsp;for diseases characterized by&nbsp;glucocerebrosidase deficiency.&nbsp;</p>. Here, GBA1 is linked to hyperinsulinemic hypoglycemia, familial, 4.